Boehringer Ingelheim

The top pharma companies in social media
Fierce Pharma
Mon, 05/4/20 - 11:02 am
social media
Boehringer Ingelheim
AbbVie
GSK
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?
Fierce Biotech
Wed, 04/15/20 - 10:52 am
COVID-19
pandemic
Merck
Januvia
diabetes
Boehringer Ingelheim
Eli Lilly
Tradjenta
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
Thu, 03/26/20 - 10:38 am
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod
Fierce Pharma
Mon, 03/23/20 - 11:54 am
Eli Lilly
Boehringer Ingelheim
Jardiance
type 1 diabetes
diabetes
empagliflozin
Lilly and Boehringer's Jardiance, chasing AZ, nabs speedy FDA review in kidney disease
Fierce Pharma
Thu, 03/12/20 - 10:57 pm
Eli Lilly
Boehringer Ingelheim
AstraZeneca
FDA
Jardiance
kidney disease
Boehringer Ingelheim's Ofev nabs FDA nod for expanded use in rare lung disease
Fierce Pharma
Mon, 03/9/20 - 11:19 pm
Boehringer Ingelheim
IPF
Ofev
FDA
ILD
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Fierce Pharma
Fri, 03/6/20 - 11:27 pm
COVID-19
coronaviruses
Roche
GSK
Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Amgen
Biogen
Mylan
Boehringer bags CHMP backing for Ofev in rare lung disease
Pharmaforum
Mon, 03/2/20 - 10:23 am
Boehringer Ingelheim
Ofev
Europe
CHMP
scleroderma
Boehringer Ingelheim enters discovery stage collaboration with Trutino Biosciences
Pharmaceutical Business Review
Fri, 02/28/20 - 10:31 am
Boehringer Ingelheim
Trutino Biosciences
R&D
FDA Approves Eli Lilly's and Boehringer Ingelheim Pharmaceuticals' Triple-Combination Diabetes Drug Trijardy XR
Motley Fool
Tue, 01/28/20 - 12:04 pm
FDA
Eli Lilly
Boehringer Ingelheim
Trijardy XR
Jardiance
Tradjenta
metformin
diabetes
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
Motley Fool
Wed, 01/15/20 - 10:56 am
AbbVie
Boehringer Ingelheim
Skyrizi
Novartis
Cosentyx
psoriasis
Boehringer Ingelheim inks 'Singapore's largest biotech deal,' promising $1B each for a suite of anti-fibrotic IL-11 drugs
Endpoints
Thu, 01/9/20 - 09:59 am
Boehringer Ingelheim
Singapore
fibrotic disease
Boehringer cleared to manufacture BeiGene’s cancer drug for Chinese market
Pharmaforum
Fri, 01/3/20 - 09:45 am
Boehringer Ingelheim
China
BeiGene
drug manufacturing
As NASH shifts again, the focus remains on Genfit’s big readout
EP Vantage
Wed, 12/18/19 - 10:53 am
NASH
Genfit
elafibranor
Pfizer
Boehringer Ingelheim
Gilead Sciences
Poxel
Takeda
Intercept Pharma
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Pharmaceutical Business Review
Mon, 12/16/19 - 10:35 am
Jardiance
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
chronic heart failure
clinical trials
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Fri, 12/13/19 - 09:05 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
Mon, 11/18/19 - 10:29 am
diabetes
AHA
heart failure
Eli Lilly
Boehringer Ingelheim
Jardiance
clinical trials
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
Zacks.com
Thu, 11/14/19 - 10:25 am
Eli Lilly
Boehringer Ingelheim
FDA
Jardiance
type 1 diabetes
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Wed, 11/13/19 - 10:02 am
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Lilly and Boehringer rejig diabetes alliance as Jardiance soars
Pharmaforum
Tue, 11/5/19 - 10:21 am
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
type 2 diabetes

Pages